Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 24-Jun-21 5:46 PM View:  | Matinas Biopharma Holdings,... (MTNB) | 19-Jun-21 | Conversion | 24,000 | -- | -- | 4% 621.16K to 645.16K | |
| 24-Jun-21 5:46 PM View: | Matinas Biopharma Holdings,... (MTNB) | 19-Jun-21 | Acquisition (other) | 4,800 | -- | -- | < 1% 645.16K to 649.96K | |
| 24-Jun-20 9:00 PM View: | Matinas Biopharma Holdings,... (MTNB) | 23-Jun-20 | Acquisition (other) | 3,600 | -- | -- | < 1% 617.56K to 621.16K | |
| 03-Jan-20 4:06 PM View: | Matinas Biopharma Holdings,... (MTNB) | 31-Dec-19 | Grant | 8,260 | -- | -- | 1% 609.3K to 617.56K | |
| 02-Oct-19 6:06 PM View: | Matinas Biopharma Holdings,... (MTNB) | 30-Sep-19 | Grant | 29,739 | -- | -- | 5% 577.16K to 606.9K | |
| 22-Aug-19 4:30 PM View: | Aquestive Therapeutics, Inc. (AQST) | 21-Aug-19 | Market Purchase | 900 | $3.81 | $3,429.00 | 3% 30.73K to 31.64K | 71% |
| 22-Aug-19 4:30 PM View: | Aquestive Therapeutics, Inc. (AQST) | 20-Aug-19 | Market Purchase | 11,310 | $3.80 | $43,000.60 | 58% 19.43K to 30.73K | 72% |
| 22-Aug-19 4:30 PM View: | Aquestive Therapeutics, Inc. (AQST) | 19-Aug-19 | Market Purchase | 10,761 | $3.77 | $40,547.40 | 124% 8.66K to 19.43K | 73% |
| 02-Jul-19 6:42 PM View: | Matinas Biopharma Holdings,... (MTNB) | 30-Jun-19 | Grant | 21,879 | -- | -- | 4% 555.28K to 577.16K | |
| 02-Oct-19 6:06 PM View: | Matinas Biopharma Holdings,... (MTNB) | 21-Jun-19 | Acquisition (other) | 2,400 | -- | -- | < 1% 606.9K to 609.3K | |
| 03-Apr-19 4:40 PM View: | Matinas Biopharma Holdings,... (MTNB) | 31-Mar-19 | Grant | 17,202 | -- | -- | 3% 538.08K to 555.28K | |
| 04-Jan-19 4:01 PM View: | Matinas Biopharma Holdings,... (MTNB) | 31-Dec-18 | Grant | 31,513 | -- | -- | 6% 506.56K to 538.08K | |
| 03-Oct-18 4:27 PM View: | Matinas Biopharma Holdings,... (MTNB) | 01-Oct-18 | Grant | 20,381 | -- | -- | 4% 486.18K to 506.56K | |
| 11-Jul-18 4:38 PM View: | Matinas Biopharma Holdings,... (MTNB) | 29-Jun-18 | Grant | 43,203 | -- | -- | 10% 442.98K to 486.18K | |
| 02-Apr-18 5:12 PM View: | Matinas Biopharma Holdings,... (MTNB) | 30-Mar-18 | Grant | 24,672 | -- | -- | 6% 418.31K to 442.98K | |
| 07-Sep-17 5:04 PM View: | Matinas Biopharma Holdings,... (MTNB) | 07-Sep-17 | Market Purchase | 5,000 | $1.29 | $6,450.00 | 1% 413.31K to 418.31K | (31%) |
| 07-Jun-17 7:00 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 05-Jun-17 | Market Sale | 1,966 | $43.32 | $85,169.10 | (7%) 27.08K to 25.12K | (37%) |
| 17-May-17 6:44 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 15-May-17 | Option Exercise | 20,000 | $5.49 | $109,800.00 | 74% 27.08K to 47.08K | |
| 17-May-17 6:44 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 15-May-17 | Market Option Sale (Planned) | 20,000 | $51.20 | $1,024,000.00 | (42%) 47.08K to 27.08K | (16%) |
| 19-Jan-17 6:50 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 17-Jan-17 | Option Exercise | 20,000 | $5.03 | $100,593.00 | 74% 27.08K to 47.08K | |
| 19-Jan-17 6:50 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 17-Jan-17 | Market Option Sale (Planned) | 20,000 | $38.53 | $770,698.00 | (42%) 47.08K to 27.08K | (54%) |
| 17-Nov-16 5:41 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 15-Nov-16 | Option Exercise | 20,000 | $1.61 | $32,200.00 | 74% 27.08K to 47.08K | |
| 17-Nov-16 5:41 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 15-Nov-16 | Market Option Sale (Planned) | 20,000 | $36.50 | $730,000.00 | (42%) 47.08K to 27.08K | (62%) |
| 17-Aug-16 7:45 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 15-Aug-16 | Option Exercise | 25,000 | $1.61 | $40,250.00 | 92% 27.08K to 52.08K | |
| 17-Aug-16 7:45 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 15-Aug-16 | Market Option Sale (Planned) | 25,000 | $45.21 | $1,130,250.00 | (48%) 52.08K to 27.08K | (31%) |
| 17-Jun-16 4:57 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 15-Jun-16 | Grant | 16,250 | -- | -- | 155% 10.5K to 26.75K | |
| 14-Sep-15 5:59 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 11-Sep-15 | Market Purchase | 5,000 | $61.37 | $306,850.00 | 91% 5.5K to 10.5K | (3%) |
| 09-Feb-15 9:13 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Feb-15 | Option Exercise | 15,000 | $1.61 | $24,150.00 | 287% 5.23K to 20.23K | |
| 09-Feb-15 9:13 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Feb-15 | Market Option Sale (Planned) | 15,000 | $111.22 | $1,668,370.00 | (74%) 20.23K to 5.23K | 47% |
| 12-Nov-14 10:00 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 07-Nov-14 | Option Exercise | 15,000 | $1.61 | $24,150.00 | 300% 5.0K to 20.0K | |
| 12-Nov-14 10:00 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 07-Nov-14 | Market Option Sale (Planned) | 15,000 | $87.18 | $1,307,640.00 | (75%) 20.0K to 5.0K | 32% |
| 11-Aug-14 7:33 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 08-Aug-14 | Option Exercise | 15,000 | $1.61 | $24,150.00 | 300% 5.0K to 20.0K | |
| 11-Aug-14 7:33 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 08-Aug-14 | Market Option Sale (Planned) | 15,000 | $99.63 | $1,494,400.00 | (75%) 20.0K to 5.0K | 41% |
| 09-May-14 8:27 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 08-May-14 | Option Exercise | 15,000 | $1.61 | $24,150.00 | 300% 5.0K to 20.0K | |
| 09-May-14 8:27 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 08-May-14 | Market Option Sale (Planned) | 15,000 | $75.05 | $1,125,680.00 | (75%) 20.0K to 5.0K | 21% |
| 02-Jan-14 4:38 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 30-Dec-13 | Option Exercise | 10,000 | $1.61 | $16,100.00 | 200% 5.0K to 15.0K | |
| 02-Jan-14 4:38 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 30-Dec-13 | Market Option Sale (Planned) | 10,000 | $55.55 | $555,500.00 | (67%) 15.0K to 5.0K | (7%) |
| 02-Oct-13 7:10 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 30-Sep-13 | Option Exercise | 10,000 | $1.61 | $16,100.00 | 200% 5.0K to 15.0K | |
| 02-Oct-13 7:10 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 30-Sep-13 | Market Option Sale (Planned) | 10,000 | $46.74 | $467,400.00 | (67%) 15.0K to 5.0K | (27%) |
| 22-Aug-13 4:53 PM View: | Nephros Inc. (NEPH) | 20-Aug-13 | Grant | 12,078 | -- | -- | 23% 52.06K to 64.13K | |
| 02-Jul-13 5:56 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 28-Jun-13 | Option Exercise | 10,000 | $1.61 | $16,100.00 | 200% 5.0K to 15.0K | |
| 02-Jul-13 5:56 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 28-Jun-13 | Market Option Sale (Planned) | 10,000 | $28.05 | $280,460.00 | (67%) 15.0K to 5.0K | (111%) |
| 11-Jun-13 4:37 PM View: | Nephros Inc. (NEPH) | 23-May-13 | Grant | 52,056 | -- | -- | 100% 0 to 52.06K | |
| 01-Apr-13 6:23 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 28-Mar-13 | Option Exercise | 10,000 | $1.61 | $16,100.00 | 200% 5.0K to 15.0K | |
| 01-Apr-13 6:23 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 28-Mar-13 | Market Option Sale (Planned) | 10,000 | $28.49 | $284,900.00 | (67%) 15.0K to 5.0K | (108%) |
| 16-Feb-11 6:53 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 15-Feb-11 | Market Purchase | 5,000 | $7.04 | $35,200.00 | 100% 0 to 5.0K | 742% |